E3 SUMO-protein ligase PIAS4
Definition:
References:
-
[1]. Lalitha Subramanian, et al. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J Biol Chem. 2003 Mar 14;278(11):9134-41. [Content Brief]
[2]. Hideki Yamamoto, et al. Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J. 2003 May 1;22(9):2047-59. [Content Brief]
[3]. Y Shinbo, et al. Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ. 2006 Jan;13(1):96-108. [Content Brief]
[4]. B Liu, et al. A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3203-7. [Content Brief]
[5]. Dragomir B Krastev, et al. The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. Nat Cell Biol. 2022 Jan;24(1):62-73. [Content Brief]
[6]. Motomasa Ihara, et al. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4. Mol Cell Biol. 2005 May;25(9):3506-18. [Content Brief]
[7]. Jannie Rendtlew Danielsen, et al. DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a novel SUMO-binding Zinc finger. J Cell Biol. 2012 Apr 16;197(2):179-87. [Content Brief]
[8]. V Nelson, et al. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis. Apoptosis. 2001 Jun;6(3):221-34. [Content Brief]
[9]. Øyvind Dahle, et al. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner. Eur J Biochem. 2003 Mar;270(6):1338-48. [Content Brief]
[10]. Lin Cong, et al. SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function. J Biol Chem. 2011 Dec 23;286(51):43793-43808. [Content Brief]
[11]. Shan-Shan Gao, et al. TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase cells: Facilitating homologous recombination and emerging target for cancer therapy. Sci Adv. 2020 Jul 10;6(28):eaba7822. [Content Brief]